Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders

NCT ID: NCT06636474

Last Updated: 2024-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-27

Study Completion Date

2030-12-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Access to housing, in the current context of extreme tension in the rental housing market in Paris and throughout the Ile-de-France region, is proving to be extremely complex for people with mental health problems.National and international scientific studies have quantified the problem of homelessness and precarious or inappropriate housing among patients suffering from psychiatric disorders, and show the impact of housing problems on the consumption of psychiatric care.The DÉLAI's mission is to facilitate access to housing for people enrolled in a psychiatric care pathway, with teams from the psychiatric sectors

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Written and oral information provided to the patient by the patient's referring psychiatrist (Investigator of one of the five recruiting sites) during a regular consultation appointment.
* Initial assessment (V inclusion): reminder of the information concerning the research, collection of consent, collection of sociodemographic data, and standardized assessment scales (quality of life, clinical state, level of functioning) + standardized semi-structured interview for the diagnosis of psychiatric disorders + completion by the referring psychiatrist of the data corresponding to the patient's care pathway.
* Then follow-up visit at an annual rate (V1 ... VX), and DLAI exit assessment (V exit) as soon as the patient stops benefiting from the DLAI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mental Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All patients benefiting from a DLAI and suffering from psychiatric disorders, monitored in sector 75G08-09 of the Saint-Maurice hospitals, and sectors 75G19, 75G20-21, 75G25, 75G26 of the GHU Paris.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with mental disorders

administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research

Group Type OTHER

patients with mental disorders

Intervention Type OTHER

administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

patients with mental disorders

administration of standardized questionnaires and scales, upon entering the research, then annually, and finally upon leaving the research

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

patient followed for a psychiatric disorder patient benefiting from a DLAI

Exclusion Criteria

patient not followed for psychiatric disorder patient who refused to participate in the research
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier St Anne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Sainte Anne

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexandra PHAM-scottez, Pr

Role: CONTACT

+ 33 (0)1 45 65 83 70 / 81 08

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexandra PHAM - SCOTTEZ, MD

Role: primary

+33 145 65 89 18

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D20-P007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.